Literature DB >> 7181952

Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein.

S Urien, E Albengres, R Zini, J P Tillement.   

Abstract

The binding of some acidic drugs to alpha 1-AGP was studied by equilibrium dialysis at 37 degrees, pH 7.4. Certain acidic drugs bound to alpha 1-AGP at one binding site with a high affinity. Though the alpha 1-AGP plasma concentration is far lower than the HSA concentration, the association constants of some acidic drugs with alpha 1-AGP are high enough to suggest that binding to alpha 1-AGP will contribute significantly to the total plasma binding of these drugs.

Mesh:

Substances:

Year:  1982        PMID: 7181952     DOI: 10.1016/0006-2952(82)90597-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  21 in total

Review 1.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

2.  pH-dependency of basic ligand binding to alpha 1-acid glycoprotein (orosomucoid).

Authors:  S Urien; F Brée; B Testa; J P Tillement
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

3.  Characterization of binding of raltegravir to plasma proteins.

Authors:  Caroline Barau; Valérie Furlan; Yazdan Yazdanpanah; Catherine Fagard; Jean-Michel Molina; Anne-Marie Taburet; Aurélie Barrail-Tran
Journal:  Antimicrob Agents Chemother       Date:  2013-07-15       Impact factor: 5.191

4.  Selectivity in the binding of psychotropic drugs to the variants of alpha-1 acid glycoprotein.

Authors:  C B Eap; C Cuendet; P Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

5.  Relevance of the hydrolysis and protein binding of melphalan to the treatment of multiple myeloma.

Authors:  S Gera; E Musch; H K Osterheld; U Loos
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

6.  Drug binding to alpha 1-acid glycoprotein studied by circular dichroism.

Authors:  M Otagiri; R Yamamichi; T Maruyama; T Imai; A Suenaga; Y Imamura; K Kimachi
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

7.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 8.  Warfarin therapy: in need of improvement after all these years.

Authors:  Stephen E Kimmel
Journal:  Expert Opin Pharmacother       Date:  2008-04       Impact factor: 3.889

9.  Influence of ORM1 polymorphisms on the maintenance stable warfarin dosage.

Authors:  Lian Sheng Wang; Jing Jing Shang; Shu Ya Shi; Yan Qing Zhang; Jian Lin; Zhi Hua Guo; Yi Chen Wang; Jie Tang; Jie Liu; Ying Zi Liu; Zhi Li; Zhi Rong Tan; Hong Hao Zhou; Hai He Jiang; Hai Tang Xie
Journal:  Eur J Clin Pharmacol       Date:  2012-12-04       Impact factor: 2.953

Review 10.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.